Genomics & Genetics Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Chronic Liver Disease

Chronic liver disease progression involves the hepatic growth hormone receptor

U.V. Gentilucci and colleagues, University of Rome Campus of Biomedicine, wrote that the study was done "to evaluate the cytoplasmic and nuclear expression of hepatic growth hormone receptor (GHR) in different stages (S-0, S-1, S-3 and S-4, according to Knodell's classification) of chronic liver disease (CLD) and in hepatocellular carcinoma (HCC)."

"Liver specimens from 31 patients with hepatitis C virus-related CLD, five patients with HCC and nine controls were examined for...

• View Other Issues of Genomics & Genetics Weekly
  
• View Other NewsRx Publications